Related Experiment Video
Updated: Mar 27, 2026
10:07
Using Learning Outcome Measures to assess Doctoral Nursing Education
Published on: June 21, 2010
19.6K
Credentials for a PharmD graduate: The voyage never ends
Mohammed Saji Salahudeen1, Prasad S Nishtala1
1School of Pharmacy, University of Otago, Dunedin, New Zealand.
SAGE Open Medicine
|January 16, 2016
Summary
Doctor of Pharmacy (PharmD) graduates can advance careers with specialized credentials. This review highlights post-PharmD educational opportunities to optimize pharmaceutical care in clinical settings.
Area of Science:
- Pharmacy Education
- Clinical Pharmacy Practice
Background:
- Doctor of Pharmacy (PharmD) is a global professional degree.
- Graduates outside Western countries are less familiar with PharmD career paths.
Purpose of the Study:
- To review credential programs for PharmD graduates.
- To highlight career advancement opportunities for PharmD holders.
Main Methods:
- Literature review of post-PharmD educational opportunities.
- Identification of credentials for specialized practice.
Main Results:
- Numerous credential programs exist for PharmD graduates.
- Credentials enhance pharmaceutical care in geriatrics and ambulatory medicine.
Conclusions:
- Post-PharmD credentials offer significant career advancement.
- Specialized education optimizes professional practice for pharmacy graduates.
More Related Videos
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
345
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
345
01:26Pharmaceutical Poisoning: Potential Scenarios
76
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
76
01:26Pharmaceutical Equivalents
259
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
259
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
282
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
282
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
224
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
224
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
460
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
460